Objectives

After participating in this educational activity, attendees should be able to:
1| Compare the current FDA-approved treatments for tobacco use disorder, including varenicline, nicotine replacement therapies, and bupropion, and their effectiveness in achieving long-term smoking abstinence.
2| Discuss effective strategies to implement tobacco treatment into clinical settings.
3| Describe the potential additive harms of dual use of e-cigarettes with conventional cigarettes on health outcomes.
 
Presenter(s): 
Hasmeena Kathuria, MD, ATSF
Director, UW Center for Tobacco Research and Intervention
Jan and Kathryn Ver Hagen Professor of Translational Research in Medicine
University of Wisconsin-Madison
Chair, American Thoracic Society
 
NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Hasmeena Kathuria, MD Speaker No relevant relationships with ineligible companies to discloseno
Session date: 
10/15/2025 - 8:00am to 9:00am EDT
Location: 
Baystate Medical Center
759 Chestnut Street
Chestnut Conference Room 1A & B & Webinar
Springfield, MA 01199
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AAPA Category 1 CME credit
    Baystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
  • 1.00 ACPE Contact Hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 IPCE Credit Hour(s)
Please login or register to take this course.